Close
Nordic 9Nordic 9

Cellcolabs (private company)

Sweden cellcolabs.com
See something wrong or missing? Let us know
Offices:Stockholm
Industry:BiotechHealth services
Business model:B2B

Cellcolabs is a biotech startup from Sweden specializing in industrial GMP production of high quality stem cells (mesenchymal stromal cells) in order to make them available at scale.

Investors: we tracked 15 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 20.09M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Cellcolabs

Name Criteria
Germany Atai Life Sciences
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Sweden Cinclus Pharma
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 3
  • At least one vc investor: found 2
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
United Kingdom Sano Genetics
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 7
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Netherlands Leyden Labs
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
United Kingdom Mogrify
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 2
  • At least one vc investor: found 2
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
United Kingdom Causaly
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 5
  • At least one vc investor: found 2
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
United Kingdom Ochre Bio
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 4
  • At least one vc investor: found 2
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
France Xenothera
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 3
  • At least one vc investor: found 2
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
United Kingdom bit.bio
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 6
  • At least one vc investor: found 2
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
United Kingdom Synthace
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Top